Scroll Top
Gain Therapeutics Inc.

Target enrollment complete in Phase 1b trial of GT-02287

Parkinson’s News Today

Jul 07, 2025

Target enrollment complete in Phase 1b trial of GT-02287

Latest Articles

Clear Filters
September 10, 2025
Empowered Patient Podcast: Using AI in Drug Development to Protect Brain Enzyme Linked to Parkinson’s Disease Progression with Gene Mack Gain Therapeutics
https://empoweredpatientradio.com/using-ai-in-drug-development-to-protect-brain-enzyme-linked-to-parkinsons-disease-progression-with-gene-mack-gain-therapeutics-transcript
Read More
July 17, 2025
Financings for July 17, 2025
https://www.bioworld.com/articles/722260-financings-for-july-17-2025?v=preview
Read More
July 17, 2025
Inside AI-Powered Drug Discovery with Gain Therapeutics’ CEO Gene Mack — Episode 215
https://xtalks.com/inside-ai-powered-drug-discovery-with-gain-therapeutics-ceo-gene-mack-episode-215/
Read More